nodes	percent_of_prediction	percent_of_DWPC	metapath
Montelukast—ALOX5—hematologic cancer	0.341	1	CbGaD
Montelukast—CYP2A6—Methoxsalen—hematologic cancer	0.0309	0.0739	CbGbCtD
Montelukast—PTGS1—Bortezomib—hematologic cancer	0.0251	0.0601	CbGbCtD
Montelukast—CYP2A6—Ifosfamide—hematologic cancer	0.0225	0.0539	CbGbCtD
Montelukast—PTGS1—Thalidomide—hematologic cancer	0.0219	0.0523	CbGbCtD
Montelukast—PTGS1—Ifosfamide—hematologic cancer	0.0193	0.0461	CbGbCtD
Montelukast—PTGS1—Imatinib—hematologic cancer	0.0184	0.044	CbGbCtD
Montelukast—CYP2C9—Bexarotene—hematologic cancer	0.0165	0.0394	CbGbCtD
Montelukast—CYP2A6—Prednisolone—hematologic cancer	0.015	0.0359	CbGbCtD
Montelukast—CYP2C8—Bortezomib—hematologic cancer	0.0145	0.0347	CbGbCtD
Montelukast—CYP2C9—Idarubicin—hematologic cancer	0.0137	0.0327	CbGbCtD
Montelukast—CYP2C8—Ifosfamide—hematologic cancer	0.0111	0.0266	CbGbCtD
Montelukast—CYP2C9—Bortezomib—hematologic cancer	0.0101	0.0242	CbGbCtD
Montelukast—CYP2C8—Nilotinib—hematologic cancer	0.00965	0.0231	CbGbCtD
Montelukast—CYP3A4—Bexarotene—hematologic cancer	0.00959	0.0229	CbGbCtD
Montelukast—PTGS1—Etoposide—hematologic cancer	0.00921	0.022	CbGbCtD
Montelukast—CYP3A4—Lomustine—hematologic cancer	0.00892	0.0213	CbGbCtD
Montelukast—CYP3A4—Busulfan—hematologic cancer	0.00892	0.0213	CbGbCtD
Montelukast—CYP2A6—Dexamethasone—hematologic cancer	0.00886	0.0212	CbGbCtD
Montelukast—CYP2C9—Thalidomide—hematologic cancer	0.00881	0.0211	CbGbCtD
Montelukast—CYP2C9—Teniposide—hematologic cancer	0.0084	0.0201	CbGbCtD
Montelukast—CYP3A4—Thiotepa—hematologic cancer	0.00795	0.019	CbGbCtD
Montelukast—CYP2C9—Ifosfamide—hematologic cancer	0.00775	0.0185	CbGbCtD
Montelukast—CYP2C9—Imatinib—hematologic cancer	0.00741	0.0177	CbGbCtD
Montelukast—CYP2C9—Nilotinib—hematologic cancer	0.00673	0.0161	CbGbCtD
Montelukast—CYP3A4—Methoxsalen—hematologic cancer	0.00618	0.0148	CbGbCtD
Montelukast—CYP3A4—Bortezomib—hematologic cancer	0.00588	0.0141	CbGbCtD
Montelukast—CYP3A4—Daunorubicin—hematologic cancer	0.00562	0.0134	CbGbCtD
Montelukast—CYP2C8—Etoposide—hematologic cancer	0.00531	0.0127	CbGbCtD
Montelukast—CYP3A4—Cytarabine—hematologic cancer	0.00496	0.0119	CbGbCtD
Montelukast—CYP3A4—Teniposide—hematologic cancer	0.00489	0.0117	CbGbCtD
Montelukast—CYP3A4—Ifosfamide—hematologic cancer	0.00451	0.0108	CbGbCtD
Montelukast—CYP2C8—Dexamethasone—hematologic cancer	0.00437	0.0104	CbGbCtD
Montelukast—CYP3A4—Imatinib—hematologic cancer	0.00431	0.0103	CbGbCtD
Montelukast—CYP3A4—Ruxolitinib—hematologic cancer	0.00406	0.0097	CbGbCtD
Montelukast—CYP3A4—Nilotinib—hematologic cancer	0.00391	0.00936	CbGbCtD
Montelukast—CYP3A4—Vinorelbine—hematologic cancer	0.00388	0.00928	CbGbCtD
Montelukast—CYP2C9—Cisplatin—hematologic cancer	0.00377	0.00902	CbGbCtD
Montelukast—CYP3A4—Triamcinolone—hematologic cancer	0.00355	0.00849	CbGbCtD
Montelukast—CYP3A4—Dasatinib—hematologic cancer	0.00346	0.00827	CbGbCtD
Montelukast—CYP3A4—Mitoxantrone—hematologic cancer	0.00342	0.00817	CbGbCtD
Montelukast—CYP2C9—Dexamethasone—hematologic cancer	0.00305	0.00729	CbGbCtD
Montelukast—CYP3A4—Betamethasone—hematologic cancer	0.00305	0.00728	CbGbCtD
Montelukast—CYP3A4—Prednisolone—hematologic cancer	0.00301	0.00719	CbGbCtD
Montelukast—CYP3A4—Prednisone—hematologic cancer	0.00284	0.00679	CbGbCtD
Montelukast—CYP3A4—Irinotecan—hematologic cancer	0.00269	0.00643	CbGbCtD
Montelukast—CYSLTR1—hematopoietic system—hematologic cancer	0.00246	0.107	CbGeAlD
Montelukast—CYP3A4—Vinblastine—hematologic cancer	0.00239	0.00572	CbGbCtD
Montelukast—CYP3A4—Vincristine—hematologic cancer	0.00235	0.00562	CbGbCtD
Montelukast—CYP3A4—Etoposide—hematologic cancer	0.00215	0.00515	CbGbCtD
Montelukast—CYP3A4—Dexamethasone—hematologic cancer	0.00177	0.00424	CbGbCtD
Montelukast—CYSLTR1—blood—hematologic cancer	0.00163	0.0712	CbGeAlD
Montelukast—CYSLTR1—bone marrow—hematologic cancer	0.00157	0.0689	CbGeAlD
Montelukast—ALOX5—hematopoietic system—hematologic cancer	0.00149	0.0651	CbGeAlD
Montelukast—CYP3A4—Doxorubicin—hematologic cancer	0.00147	0.00351	CbGbCtD
Montelukast—CYSLTR1—lung—hematologic cancer	0.00143	0.0624	CbGeAlD
Montelukast—SLCO2B1—hematopoietic system—hematologic cancer	0.00114	0.0501	CbGeAlD
Montelukast—ALOX5—blood—hematologic cancer	0.000985	0.0431	CbGeAlD
Montelukast—CYSLTR1—lymph node—hematologic cancer	0.000976	0.0427	CbGeAlD
Montelukast—ALOX5—bone marrow—hematologic cancer	0.000953	0.0417	CbGeAlD
Montelukast—ALOX5—lung—hematologic cancer	0.000864	0.0378	CbGeAlD
Montelukast—ALOX5—testis—hematologic cancer	0.000815	0.0357	CbGeAlD
Montelukast—CYP2A6—lung—hematologic cancer	0.000762	0.0333	CbGeAlD
Montelukast—CYP2C8—hematopoietic system—hematologic cancer	0.000736	0.0322	CbGeAlD
Montelukast—SLCO2B1—lung—hematologic cancer	0.000665	0.0291	CbGeAlD
Montelukast—CYP2C9—hematopoietic system—hematologic cancer	0.000654	0.0286	CbGeAlD
Montelukast—SLCO2B1—testis—hematologic cancer	0.000627	0.0275	CbGeAlD
Montelukast—PTGS1—hematopoietic system—hematologic cancer	0.000597	0.0261	CbGeAlD
Montelukast—ALOX5—lymph node—hematologic cancer	0.000591	0.0258	CbGeAlD
Montelukast—CYP3A4—hematopoietic system—hematologic cancer	0.000499	0.0218	CbGeAlD
Montelukast—CYP2C8—blood—hematologic cancer	0.000488	0.0213	CbGeAlD
Montelukast—SLCO2B1—lymph node—hematologic cancer	0.000455	0.0199	CbGeAlD
Montelukast—CYP2C9—blood—hematologic cancer	0.000433	0.019	CbGeAlD
Montelukast—CYP2C8—testis—hematologic cancer	0.000403	0.0177	CbGeAlD
Montelukast—PTGS1—blood—hematologic cancer	0.000395	0.0173	CbGeAlD
Montelukast—PTGS1—lung—hematologic cancer	0.000347	0.0152	CbGeAlD
Montelukast—CYP3A4—blood—hematologic cancer	0.00033	0.0145	CbGeAlD
Montelukast—PTGS1—testis—hematologic cancer	0.000327	0.0143	CbGeAlD
Montelukast—PTGS1—lymph node—hematologic cancer	0.000237	0.0104	CbGeAlD
Montelukast—Headache—Vincristine—hematologic cancer	2.92e-05	0.000165	CcSEcCtD
Montelukast—Hepatobiliary disease—Doxorubicin—hematologic cancer	2.91e-05	0.000164	CcSEcCtD
Montelukast—Nausea—Carmustine—hematologic cancer	2.9e-05	0.000164	CcSEcCtD
Montelukast—Epistaxis—Doxorubicin—hematologic cancer	2.9e-05	0.000163	CcSEcCtD
Montelukast—Vomiting—Irinotecan—hematologic cancer	2.89e-05	0.000163	CcSEcCtD
Montelukast—Vomiting—Mitoxantrone—hematologic cancer	2.89e-05	0.000163	CcSEcCtD
Montelukast—Sinusitis—Doxorubicin—hematologic cancer	2.88e-05	0.000163	CcSEcCtD
Montelukast—Immune system disorder—Methotrexate—hematologic cancer	2.88e-05	0.000162	CcSEcCtD
Montelukast—Nausea—Alitretinoin—hematologic cancer	2.88e-05	0.000162	CcSEcCtD
Montelukast—Convulsion—Prednisone—hematologic cancer	2.88e-05	0.000162	CcSEcCtD
Montelukast—Mediastinal disorder—Methotrexate—hematologic cancer	2.87e-05	0.000162	CcSEcCtD
Montelukast—Rash—Irinotecan—hematologic cancer	2.87e-05	0.000162	CcSEcCtD
Montelukast—Rash—Mitoxantrone—hematologic cancer	2.87e-05	0.000162	CcSEcCtD
Montelukast—Dermatitis—Mitoxantrone—hematologic cancer	2.86e-05	0.000161	CcSEcCtD
Montelukast—Dermatitis—Irinotecan—hematologic cancer	2.86e-05	0.000161	CcSEcCtD
Montelukast—Headache—Mitoxantrone—hematologic cancer	2.85e-05	0.00016	CcSEcCtD
Montelukast—Headache—Irinotecan—hematologic cancer	2.85e-05	0.00016	CcSEcCtD
Montelukast—Nausea—Ifosfamide—hematologic cancer	2.84e-05	0.00016	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2.83e-05	0.00016	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2.83e-05	0.00016	CcSEcCtD
Montelukast—Arthralgia—Prednisone—hematologic cancer	2.83e-05	0.000159	CcSEcCtD
Montelukast—Myalgia—Prednisone—hematologic cancer	2.83e-05	0.000159	CcSEcCtD
Montelukast—Diarrhoea—Cisplatin—hematologic cancer	2.82e-05	0.000159	CcSEcCtD
Montelukast—Erythema multiforme—Epirubicin—hematologic cancer	2.82e-05	0.000159	CcSEcCtD
Montelukast—Anxiety—Prednisone—hematologic cancer	2.82e-05	0.000159	CcSEcCtD
Montelukast—Vomiting—Gemcitabine—hematologic cancer	2.82e-05	0.000159	CcSEcCtD
Montelukast—Insomnia—Dexamethasone—hematologic cancer	2.81e-05	0.000159	CcSEcCtD
Montelukast—Insomnia—Betamethasone—hematologic cancer	2.81e-05	0.000159	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	2.81e-05	0.000158	CcSEcCtD
Montelukast—Paraesthesia—Dexamethasone—hematologic cancer	2.79e-05	0.000157	CcSEcCtD
Montelukast—Paraesthesia—Betamethasone—hematologic cancer	2.79e-05	0.000157	CcSEcCtD
Montelukast—Mental disorder—Methotrexate—hematologic cancer	2.79e-05	0.000157	CcSEcCtD
Montelukast—Rash—Gemcitabine—hematologic cancer	2.79e-05	0.000157	CcSEcCtD
Montelukast—Dermatitis—Gemcitabine—hematologic cancer	2.79e-05	0.000157	CcSEcCtD
Montelukast—Hypersensitivity—Etoposide—hematologic cancer	2.79e-05	0.000157	CcSEcCtD
Montelukast—Headache—Gemcitabine—hematologic cancer	2.77e-05	0.000156	CcSEcCtD
Montelukast—Nausea—Vincristine—hematologic cancer	2.77e-05	0.000156	CcSEcCtD
Montelukast—Cardiac disorder—Epirubicin—hematologic cancer	2.77e-05	0.000156	CcSEcCtD
Montelukast—Rhinitis—Doxorubicin—hematologic cancer	2.77e-05	0.000156	CcSEcCtD
Montelukast—Hepatitis—Doxorubicin—hematologic cancer	2.76e-05	0.000156	CcSEcCtD
Montelukast—Hypersensitivity—Prednisolone—hematologic cancer	2.75e-05	0.000155	CcSEcCtD
Montelukast—Hypoaesthesia—Doxorubicin—hematologic cancer	2.75e-05	0.000155	CcSEcCtD
Montelukast—Pharyngitis—Doxorubicin—hematologic cancer	2.74e-05	0.000154	CcSEcCtD
Montelukast—Dyspepsia—Dexamethasone—hematologic cancer	2.74e-05	0.000154	CcSEcCtD
Montelukast—Dyspepsia—Betamethasone—hematologic cancer	2.74e-05	0.000154	CcSEcCtD
Montelukast—Urinary tract disorder—Doxorubicin—hematologic cancer	2.73e-05	0.000154	CcSEcCtD
Montelukast—Urticaria—Triamcinolone—hematologic cancer	2.72e-05	0.000154	CcSEcCtD
Montelukast—Asthenia—Etoposide—hematologic cancer	2.71e-05	0.000153	CcSEcCtD
Montelukast—Connective tissue disorder—Doxorubicin—hematologic cancer	2.71e-05	0.000153	CcSEcCtD
Montelukast—Body temperature increased—Triamcinolone—hematologic cancer	2.71e-05	0.000153	CcSEcCtD
Montelukast—Oedema—Prednisone—hematologic cancer	2.71e-05	0.000153	CcSEcCtD
Montelukast—Anaphylactic shock—Prednisone—hematologic cancer	2.71e-05	0.000153	CcSEcCtD
Montelukast—Urethral disorder—Doxorubicin—hematologic cancer	2.71e-05	0.000152	CcSEcCtD
Montelukast—Nausea—Irinotecan—hematologic cancer	2.7e-05	0.000152	CcSEcCtD
Montelukast—Nausea—Mitoxantrone—hematologic cancer	2.7e-05	0.000152	CcSEcCtD
Montelukast—Immune system disorder—Epirubicin—hematologic cancer	2.69e-05	0.000152	CcSEcCtD
Montelukast—Infection—Prednisone—hematologic cancer	2.69e-05	0.000152	CcSEcCtD
Montelukast—Mediastinal disorder—Epirubicin—hematologic cancer	2.69e-05	0.000152	CcSEcCtD
Montelukast—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.69e-05	0.000151	CcSEcCtD
Montelukast—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.69e-05	0.000151	CcSEcCtD
Montelukast—Fatigue—Betamethasone—hematologic cancer	2.68e-05	0.000151	CcSEcCtD
Montelukast—Fatigue—Dexamethasone—hematologic cancer	2.68e-05	0.000151	CcSEcCtD
Montelukast—Pruritus—Etoposide—hematologic cancer	2.67e-05	0.000151	CcSEcCtD
Montelukast—Pain—Betamethasone—hematologic cancer	2.66e-05	0.00015	CcSEcCtD
Montelukast—Pain—Dexamethasone—hematologic cancer	2.66e-05	0.00015	CcSEcCtD
Montelukast—Nervous system disorder—Prednisone—hematologic cancer	2.66e-05	0.00015	CcSEcCtD
Montelukast—Skin disorder—Prednisone—hematologic cancer	2.63e-05	0.000148	CcSEcCtD
Montelukast—Nausea—Gemcitabine—hematologic cancer	2.63e-05	0.000148	CcSEcCtD
Montelukast—Vomiting—Cisplatin—hematologic cancer	2.62e-05	0.000148	CcSEcCtD
Montelukast—Mental disorder—Epirubicin—hematologic cancer	2.61e-05	0.000147	CcSEcCtD
Montelukast—Erythema multiforme—Doxorubicin—hematologic cancer	2.61e-05	0.000147	CcSEcCtD
Montelukast—Rash—Cisplatin—hematologic cancer	2.6e-05	0.000147	CcSEcCtD
Montelukast—Dermatitis—Cisplatin—hematologic cancer	2.6e-05	0.000147	CcSEcCtD
Montelukast—Diarrhoea—Etoposide—hematologic cancer	2.59e-05	0.000146	CcSEcCtD
Montelukast—Cardiac disorder—Doxorubicin—hematologic cancer	2.56e-05	0.000144	CcSEcCtD
Montelukast—Gastrointestinal pain—Betamethasone—hematologic cancer	2.54e-05	0.000143	CcSEcCtD
Montelukast—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.54e-05	0.000143	CcSEcCtD
Montelukast—Hypersensitivity—Triamcinolone—hematologic cancer	2.53e-05	0.000142	CcSEcCtD
Montelukast—Dizziness—Etoposide—hematologic cancer	2.5e-05	0.000141	CcSEcCtD
Montelukast—Muscle spasms—Epirubicin—hematologic cancer	2.5e-05	0.000141	CcSEcCtD
Montelukast—Immune system disorder—Doxorubicin—hematologic cancer	2.49e-05	0.000141	CcSEcCtD
Montelukast—Mediastinal disorder—Doxorubicin—hematologic cancer	2.49e-05	0.00014	CcSEcCtD
Montelukast—Urticaria—Dexamethasone—hematologic cancer	2.47e-05	0.000139	CcSEcCtD
Montelukast—Urticaria—Betamethasone—hematologic cancer	2.47e-05	0.000139	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.47e-05	0.000139	CcSEcCtD
Montelukast—Dizziness—Prednisolone—hematologic cancer	2.47e-05	0.000139	CcSEcCtD
Montelukast—Asthenia—Triamcinolone—hematologic cancer	2.46e-05	0.000139	CcSEcCtD
Montelukast—Body temperature increased—Betamethasone—hematologic cancer	2.46e-05	0.000139	CcSEcCtD
Montelukast—Body temperature increased—Dexamethasone—hematologic cancer	2.46e-05	0.000139	CcSEcCtD
Montelukast—Abdominal pain—Dexamethasone—hematologic cancer	2.46e-05	0.000139	CcSEcCtD
Montelukast—Abdominal pain—Betamethasone—hematologic cancer	2.46e-05	0.000139	CcSEcCtD
Montelukast—Nausea—Cisplatin—hematologic cancer	2.45e-05	0.000138	CcSEcCtD
Montelukast—Insomnia—Prednisone—hematologic cancer	2.45e-05	0.000138	CcSEcCtD
Montelukast—Paraesthesia—Prednisone—hematologic cancer	2.43e-05	0.000137	CcSEcCtD
Montelukast—Pruritus—Triamcinolone—hematologic cancer	2.43e-05	0.000137	CcSEcCtD
Montelukast—Cough—Methotrexate—hematologic cancer	2.42e-05	0.000136	CcSEcCtD
Montelukast—Mental disorder—Doxorubicin—hematologic cancer	2.42e-05	0.000136	CcSEcCtD
Montelukast—Convulsion—Methotrexate—hematologic cancer	2.4e-05	0.000136	CcSEcCtD
Montelukast—Vomiting—Etoposide—hematologic cancer	2.4e-05	0.000135	CcSEcCtD
Montelukast—Agitation—Epirubicin—hematologic cancer	2.39e-05	0.000134	CcSEcCtD
Montelukast—Dyspepsia—Prednisone—hematologic cancer	2.39e-05	0.000134	CcSEcCtD
Montelukast—Rash—Etoposide—hematologic cancer	2.38e-05	0.000134	CcSEcCtD
Montelukast—Dermatitis—Etoposide—hematologic cancer	2.38e-05	0.000134	CcSEcCtD
Montelukast—Headache—Etoposide—hematologic cancer	2.37e-05	0.000133	CcSEcCtD
Montelukast—Myalgia—Methotrexate—hematologic cancer	2.36e-05	0.000133	CcSEcCtD
Montelukast—Arthralgia—Methotrexate—hematologic cancer	2.36e-05	0.000133	CcSEcCtD
Montelukast—Rash—Prednisolone—hematologic cancer	2.35e-05	0.000133	CcSEcCtD
Montelukast—Dermatitis—Prednisolone—hematologic cancer	2.35e-05	0.000132	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.35e-05	0.000132	CcSEcCtD
Montelukast—Fatigue—Prednisone—hematologic cancer	2.34e-05	0.000132	CcSEcCtD
Montelukast—Headache—Prednisolone—hematologic cancer	2.34e-05	0.000132	CcSEcCtD
Montelukast—Muscle spasms—Doxorubicin—hematologic cancer	2.31e-05	0.00013	CcSEcCtD
Montelukast—Palpitations—Epirubicin—hematologic cancer	2.29e-05	0.000129	CcSEcCtD
Montelukast—Dizziness—Triamcinolone—hematologic cancer	2.27e-05	0.000128	CcSEcCtD
Montelukast—Cough—Epirubicin—hematologic cancer	2.27e-05	0.000128	CcSEcCtD
Montelukast—Anaphylactic shock—Methotrexate—hematologic cancer	2.26e-05	0.000128	CcSEcCtD
Montelukast—Convulsion—Epirubicin—hematologic cancer	2.25e-05	0.000127	CcSEcCtD
Montelukast—Infection—Methotrexate—hematologic cancer	2.25e-05	0.000127	CcSEcCtD
Montelukast—Nausea—Etoposide—hematologic cancer	2.25e-05	0.000127	CcSEcCtD
Montelukast—Asthenia—Dexamethasone—hematologic cancer	2.23e-05	0.000126	CcSEcCtD
Montelukast—Asthenia—Betamethasone—hematologic cancer	2.23e-05	0.000126	CcSEcCtD
Montelukast—Nervous system disorder—Methotrexate—hematologic cancer	2.22e-05	0.000125	CcSEcCtD
Montelukast—Thrombocytopenia—Methotrexate—hematologic cancer	2.22e-05	0.000125	CcSEcCtD
Montelukast—Gastrointestinal pain—Prednisone—hematologic cancer	2.22e-05	0.000125	CcSEcCtD
Montelukast—Nausea—Prednisolone—hematologic cancer	2.21e-05	0.000125	CcSEcCtD
Montelukast—Arthralgia—Epirubicin—hematologic cancer	2.21e-05	0.000125	CcSEcCtD
Montelukast—Myalgia—Epirubicin—hematologic cancer	2.21e-05	0.000125	CcSEcCtD
Montelukast—Agitation—Doxorubicin—hematologic cancer	2.21e-05	0.000124	CcSEcCtD
Montelukast—Anxiety—Epirubicin—hematologic cancer	2.2e-05	0.000124	CcSEcCtD
Montelukast—Pruritus—Betamethasone—hematologic cancer	2.2e-05	0.000124	CcSEcCtD
Montelukast—Pruritus—Dexamethasone—hematologic cancer	2.2e-05	0.000124	CcSEcCtD
Montelukast—Skin disorder—Methotrexate—hematologic cancer	2.2e-05	0.000124	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.2e-05	0.000124	CcSEcCtD
Montelukast—Vomiting—Triamcinolone—hematologic cancer	2.18e-05	0.000123	CcSEcCtD
Montelukast—Rash—Triamcinolone—hematologic cancer	2.16e-05	0.000122	CcSEcCtD
Montelukast—Dermatitis—Triamcinolone—hematologic cancer	2.16e-05	0.000122	CcSEcCtD
Montelukast—Urticaria—Prednisone—hematologic cancer	2.15e-05	0.000121	CcSEcCtD
Montelukast—Headache—Triamcinolone—hematologic cancer	2.15e-05	0.000121	CcSEcCtD
Montelukast—Abdominal pain—Prednisone—hematologic cancer	2.14e-05	0.000121	CcSEcCtD
Montelukast—Body temperature increased—Prednisone—hematologic cancer	2.14e-05	0.000121	CcSEcCtD
Montelukast—Diarrhoea—Dexamethasone—hematologic cancer	2.13e-05	0.00012	CcSEcCtD
Montelukast—Diarrhoea—Betamethasone—hematologic cancer	2.13e-05	0.00012	CcSEcCtD
Montelukast—Palpitations—Doxorubicin—hematologic cancer	2.12e-05	0.00012	CcSEcCtD
Montelukast—Anaphylactic shock—Epirubicin—hematologic cancer	2.12e-05	0.000119	CcSEcCtD
Montelukast—Oedema—Epirubicin—hematologic cancer	2.12e-05	0.000119	CcSEcCtD
Montelukast—Infection—Epirubicin—hematologic cancer	2.11e-05	0.000119	CcSEcCtD
Montelukast—Cough—Doxorubicin—hematologic cancer	2.1e-05	0.000118	CcSEcCtD
Montelukast—Convulsion—Doxorubicin—hematologic cancer	2.08e-05	0.000117	CcSEcCtD
Montelukast—Nervous system disorder—Epirubicin—hematologic cancer	2.08e-05	0.000117	CcSEcCtD
Montelukast—Thrombocytopenia—Epirubicin—hematologic cancer	2.07e-05	0.000117	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.06e-05	0.000116	CcSEcCtD
Montelukast—Skin disorder—Epirubicin—hematologic cancer	2.06e-05	0.000116	CcSEcCtD
Montelukast—Dizziness—Dexamethasone—hematologic cancer	2.06e-05	0.000116	CcSEcCtD
Montelukast—Dizziness—Betamethasone—hematologic cancer	2.06e-05	0.000116	CcSEcCtD
Montelukast—Insomnia—Methotrexate—hematologic cancer	2.05e-05	0.000115	CcSEcCtD
Montelukast—Arthralgia—Doxorubicin—hematologic cancer	2.05e-05	0.000115	CcSEcCtD
Montelukast—Myalgia—Doxorubicin—hematologic cancer	2.05e-05	0.000115	CcSEcCtD
Montelukast—Anxiety—Doxorubicin—hematologic cancer	2.04e-05	0.000115	CcSEcCtD
Montelukast—Nausea—Triamcinolone—hematologic cancer	2.04e-05	0.000115	CcSEcCtD
Montelukast—Paraesthesia—Methotrexate—hematologic cancer	2.03e-05	0.000115	CcSEcCtD
Montelukast—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.03e-05	0.000114	CcSEcCtD
Montelukast—Somnolence—Methotrexate—hematologic cancer	2.01e-05	0.000113	CcSEcCtD
Montelukast—Hypersensitivity—Prednisone—hematologic cancer	2e-05	0.000113	CcSEcCtD
Montelukast—Dyspepsia—Methotrexate—hematologic cancer	1.99e-05	0.000112	CcSEcCtD
Montelukast—Vomiting—Dexamethasone—hematologic cancer	1.98e-05	0.000112	CcSEcCtD
Montelukast—Vomiting—Betamethasone—hematologic cancer	1.98e-05	0.000112	CcSEcCtD
Montelukast—Rash—Dexamethasone—hematologic cancer	1.96e-05	0.000111	CcSEcCtD
Montelukast—Rash—Betamethasone—hematologic cancer	1.96e-05	0.000111	CcSEcCtD
Montelukast—Anaphylactic shock—Doxorubicin—hematologic cancer	1.96e-05	0.000111	CcSEcCtD
Montelukast—Oedema—Doxorubicin—hematologic cancer	1.96e-05	0.000111	CcSEcCtD
Montelukast—Dermatitis—Dexamethasone—hematologic cancer	1.96e-05	0.00011	CcSEcCtD
Montelukast—Dermatitis—Betamethasone—hematologic cancer	1.96e-05	0.00011	CcSEcCtD
Montelukast—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.96e-05	0.00011	CcSEcCtD
Montelukast—Fatigue—Methotrexate—hematologic cancer	1.95e-05	0.00011	CcSEcCtD
Montelukast—Headache—Betamethasone—hematologic cancer	1.95e-05	0.00011	CcSEcCtD
Montelukast—Headache—Dexamethasone—hematologic cancer	1.95e-05	0.00011	CcSEcCtD
Montelukast—Infection—Doxorubicin—hematologic cancer	1.95e-05	0.00011	CcSEcCtD
Montelukast—Asthenia—Prednisone—hematologic cancer	1.94e-05	0.00011	CcSEcCtD
Montelukast—Pain—Methotrexate—hematologic cancer	1.94e-05	0.000109	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.93e-05	0.000109	CcSEcCtD
Montelukast—Nervous system disorder—Doxorubicin—hematologic cancer	1.92e-05	0.000108	CcSEcCtD
Montelukast—Thrombocytopenia—Doxorubicin—hematologic cancer	1.92e-05	0.000108	CcSEcCtD
Montelukast—Pruritus—Prednisone—hematologic cancer	1.92e-05	0.000108	CcSEcCtD
Montelukast—Insomnia—Epirubicin—hematologic cancer	1.92e-05	0.000108	CcSEcCtD
Montelukast—Skin disorder—Doxorubicin—hematologic cancer	1.9e-05	0.000107	CcSEcCtD
Montelukast—Paraesthesia—Epirubicin—hematologic cancer	1.9e-05	0.000107	CcSEcCtD
Montelukast—Somnolence—Epirubicin—hematologic cancer	1.88e-05	0.000106	CcSEcCtD
Montelukast—Dyspepsia—Epirubicin—hematologic cancer	1.87e-05	0.000105	CcSEcCtD
Montelukast—Diarrhoea—Prednisone—hematologic cancer	1.85e-05	0.000104	CcSEcCtD
Montelukast—Gastrointestinal pain—Methotrexate—hematologic cancer	1.85e-05	0.000104	CcSEcCtD
Montelukast—Nausea—Betamethasone—hematologic cancer	1.85e-05	0.000104	CcSEcCtD
Montelukast—Nausea—Dexamethasone—hematologic cancer	1.85e-05	0.000104	CcSEcCtD
Montelukast—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.83e-05	0.000103	CcSEcCtD
Montelukast—Fatigue—Epirubicin—hematologic cancer	1.83e-05	0.000103	CcSEcCtD
Montelukast—Pain—Epirubicin—hematologic cancer	1.81e-05	0.000102	CcSEcCtD
Montelukast—Urticaria—Methotrexate—hematologic cancer	1.8e-05	0.000101	CcSEcCtD
Montelukast—Dizziness—Prednisone—hematologic cancer	1.79e-05	0.000101	CcSEcCtD
Montelukast—Abdominal pain—Methotrexate—hematologic cancer	1.79e-05	0.000101	CcSEcCtD
Montelukast—Body temperature increased—Methotrexate—hematologic cancer	1.79e-05	0.000101	CcSEcCtD
Montelukast—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.79e-05	0.000101	CcSEcCtD
Montelukast—Insomnia—Doxorubicin—hematologic cancer	1.77e-05	0.0001	CcSEcCtD
Montelukast—Paraesthesia—Doxorubicin—hematologic cancer	1.76e-05	9.92e-05	CcSEcCtD
Montelukast—Somnolence—Doxorubicin—hematologic cancer	1.74e-05	9.83e-05	CcSEcCtD
Montelukast—Gastrointestinal pain—Epirubicin—hematologic cancer	1.73e-05	9.77e-05	CcSEcCtD
Montelukast—Dyspepsia—Doxorubicin—hematologic cancer	1.73e-05	9.73e-05	CcSEcCtD
Montelukast—Vomiting—Prednisone—hematologic cancer	1.72e-05	9.71e-05	CcSEcCtD
Montelukast—Rash—Prednisone—hematologic cancer	1.71e-05	9.63e-05	CcSEcCtD
Montelukast—Dermatitis—Prednisone—hematologic cancer	1.71e-05	9.62e-05	CcSEcCtD
Montelukast—Headache—Prednisone—hematologic cancer	1.7e-05	9.57e-05	CcSEcCtD
Montelukast—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.69e-05	9.54e-05	CcSEcCtD
Montelukast—Fatigue—Doxorubicin—hematologic cancer	1.69e-05	9.53e-05	CcSEcCtD
Montelukast—Urticaria—Epirubicin—hematologic cancer	1.68e-05	9.49e-05	CcSEcCtD
Montelukast—Pain—Doxorubicin—hematologic cancer	1.68e-05	9.45e-05	CcSEcCtD
Montelukast—Abdominal pain—Epirubicin—hematologic cancer	1.68e-05	9.44e-05	CcSEcCtD
Montelukast—Body temperature increased—Epirubicin—hematologic cancer	1.68e-05	9.44e-05	CcSEcCtD
Montelukast—Hypersensitivity—Methotrexate—hematologic cancer	1.67e-05	9.4e-05	CcSEcCtD
Montelukast—Asthenia—Methotrexate—hematologic cancer	1.62e-05	9.16e-05	CcSEcCtD
Montelukast—Nausea—Prednisone—hematologic cancer	1.61e-05	9.07e-05	CcSEcCtD
Montelukast—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.6e-05	9.04e-05	CcSEcCtD
Montelukast—Pruritus—Methotrexate—hematologic cancer	1.6e-05	9.03e-05	CcSEcCtD
Montelukast—Hypersensitivity—Epirubicin—hematologic cancer	1.56e-05	8.8e-05	CcSEcCtD
Montelukast—Urticaria—Doxorubicin—hematologic cancer	1.56e-05	8.78e-05	CcSEcCtD
Montelukast—Body temperature increased—Doxorubicin—hematologic cancer	1.55e-05	8.74e-05	CcSEcCtD
Montelukast—Abdominal pain—Doxorubicin—hematologic cancer	1.55e-05	8.74e-05	CcSEcCtD
Montelukast—Diarrhoea—Methotrexate—hematologic cancer	1.55e-05	8.73e-05	CcSEcCtD
Montelukast—Asthenia—Epirubicin—hematologic cancer	1.52e-05	8.57e-05	CcSEcCtD
Montelukast—Pruritus—Epirubicin—hematologic cancer	1.5e-05	8.45e-05	CcSEcCtD
Montelukast—Dizziness—Methotrexate—hematologic cancer	1.5e-05	8.44e-05	CcSEcCtD
Montelukast—Diarrhoea—Epirubicin—hematologic cancer	1.45e-05	8.17e-05	CcSEcCtD
Montelukast—Hypersensitivity—Doxorubicin—hematologic cancer	1.44e-05	8.14e-05	CcSEcCtD
Montelukast—Vomiting—Methotrexate—hematologic cancer	1.44e-05	8.12e-05	CcSEcCtD
Montelukast—Rash—Methotrexate—hematologic cancer	1.43e-05	8.05e-05	CcSEcCtD
Montelukast—Dermatitis—Methotrexate—hematologic cancer	1.43e-05	8.04e-05	CcSEcCtD
Montelukast—Headache—Methotrexate—hematologic cancer	1.42e-05	8e-05	CcSEcCtD
Montelukast—Asthenia—Doxorubicin—hematologic cancer	1.41e-05	7.93e-05	CcSEcCtD
Montelukast—Dizziness—Epirubicin—hematologic cancer	1.4e-05	7.9e-05	CcSEcCtD
Montelukast—Pruritus—Doxorubicin—hematologic cancer	1.39e-05	7.82e-05	CcSEcCtD
Montelukast—Vomiting—Epirubicin—hematologic cancer	1.35e-05	7.59e-05	CcSEcCtD
Montelukast—Nausea—Methotrexate—hematologic cancer	1.35e-05	7.58e-05	CcSEcCtD
Montelukast—Diarrhoea—Doxorubicin—hematologic cancer	1.34e-05	7.56e-05	CcSEcCtD
Montelukast—Rash—Epirubicin—hematologic cancer	1.34e-05	7.53e-05	CcSEcCtD
Montelukast—Dermatitis—Epirubicin—hematologic cancer	1.33e-05	7.52e-05	CcSEcCtD
Montelukast—Headache—Epirubicin—hematologic cancer	1.33e-05	7.48e-05	CcSEcCtD
Montelukast—Dizziness—Doxorubicin—hematologic cancer	1.3e-05	7.31e-05	CcSEcCtD
Montelukast—Nausea—Epirubicin—hematologic cancer	1.26e-05	7.09e-05	CcSEcCtD
Montelukast—Vomiting—Doxorubicin—hematologic cancer	1.25e-05	7.03e-05	CcSEcCtD
Montelukast—Rash—Doxorubicin—hematologic cancer	1.24e-05	6.97e-05	CcSEcCtD
Montelukast—Dermatitis—Doxorubicin—hematologic cancer	1.24e-05	6.96e-05	CcSEcCtD
Montelukast—Headache—Doxorubicin—hematologic cancer	1.23e-05	6.92e-05	CcSEcCtD
Montelukast—Nausea—Doxorubicin—hematologic cancer	1.16e-05	6.56e-05	CcSEcCtD
Montelukast—PTGS1—Metabolism—SDC1—hematologic cancer	8.21e-06	0.000202	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3R1—hematologic cancer	8.21e-06	0.000202	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ENO2—hematologic cancer	8.19e-06	0.000202	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MTAP—hematologic cancer	8.08e-06	0.000199	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CD—hematologic cancer	8.05e-06	0.000198	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—JAK2—hematologic cancer	7.98e-06	0.000196	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—ALB—hematologic cancer	7.95e-06	0.000196	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTT1—hematologic cancer	7.94e-06	0.000195	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	7.84e-06	0.000193	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—PIK3CA—hematologic cancer	7.82e-06	0.000192	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MDM2—hematologic cancer	7.78e-06	0.000192	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—SDC1—hematologic cancer	7.76e-06	0.000191	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	7.76e-06	0.000191	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	7.74e-06	0.000191	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ARNTL—hematologic cancer	7.74e-06	0.00019	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3R1—hematologic cancer	7.61e-06	0.000187	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CB—hematologic cancer	7.57e-06	0.000186	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MTOR—hematologic cancer	7.57e-06	0.000186	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ACP5—hematologic cancer	7.53e-06	0.000185	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CA9—hematologic cancer	7.53e-06	0.000185	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NCOR2—hematologic cancer	7.43e-06	0.000183	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	7.41e-06	0.000182	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—HRAS—hematologic cancer	7.23e-06	0.000178	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—B3GAT1—hematologic cancer	7.23e-06	0.000178	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—DCK—hematologic cancer	7.23e-06	0.000178	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ASNS—hematologic cancer	7.23e-06	0.000178	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—FHL2—hematologic cancer	7.2e-06	0.000177	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CDKN1B—hematologic cancer	7.11e-06	0.000175	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—IDH1—hematologic cancer	7.08e-06	0.000174	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AGRN—hematologic cancer	7.07e-06	0.000174	CbGpPWpGaD
Montelukast—CYSLTR1—GPCR downstream signaling—AKT1—hematologic cancer	7.03e-06	0.000173	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CB—hematologic cancer	7.02e-06	0.000173	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCC3—hematologic cancer	7e-06	0.000172	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—TXN—hematologic cancer	7e-06	0.000172	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTO1—hematologic cancer	7e-06	0.000172	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CD44—hematologic cancer	6.98e-06	0.000172	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NQO1—hematologic cancer	6.98e-06	0.000172	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CASP3—hematologic cancer	6.97e-06	0.000171	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL2—hematologic cancer	6.96e-06	0.000171	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—IL6—hematologic cancer	6.92e-06	0.00017	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HDC—hematologic cancer	6.85e-06	0.000169	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SPHK1—hematologic cancer	6.85e-06	0.000169	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	6.84e-06	0.000168	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CCND1—hematologic cancer	6.78e-06	0.000167	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—JUN—hematologic cancer	6.77e-06	0.000167	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—IDH2—hematologic cancer	6.7e-06	0.000165	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HMMR—hematologic cancer	6.7e-06	0.000165	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CYCS—hematologic cancer	6.61e-06	0.000163	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NQO1—hematologic cancer	6.6e-06	0.000162	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CD44—hematologic cancer	6.6e-06	0.000162	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—UGT1A1—hematologic cancer	6.58e-06	0.000162	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—HSP90AA1—hematologic cancer	6.56e-06	0.000162	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—CDKN1A—hematologic cancer	6.56e-06	0.000161	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PTEN—hematologic cancer	6.55e-06	0.000161	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK8—hematologic cancer	6.4e-06	0.000158	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SLC22A1—hematologic cancer	6.4e-06	0.000157	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CRABP1—hematologic cancer	6.4e-06	0.000157	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling by GPCR—AKT1—hematologic cancer	6.39e-06	0.000157	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	6.32e-06	0.000155	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ARNTL—hematologic cancer	6.3e-06	0.000155	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CDA—hematologic cancer	6.27e-06	0.000154	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CYCS—hematologic cancer	6.25e-06	0.000154	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—EP300—hematologic cancer	6.24e-06	0.000154	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALOX5—hematologic cancer	6.24e-06	0.000153	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—HSP90AA1—hematologic cancer	6.21e-06	0.000153	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CA9—hematologic cancer	6.13e-06	0.000151	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ACP5—hematologic cancer	6.13e-06	0.000151	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—SRC—hematologic cancer	6.07e-06	0.000149	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PTEN—hematologic cancer	6.07e-06	0.000149	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NCOR2—hematologic cancer	6.05e-06	0.000149	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NUP98—hematologic cancer	6.04e-06	0.000149	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PC—hematologic cancer	6.04e-06	0.000149	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—VEGFA—hematologic cancer	5.91e-06	0.000145	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	5.91e-06	0.000145	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ADCY7—hematologic cancer	5.86e-06	0.000144	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NCOA3—hematologic cancer	5.86e-06	0.000144	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—STAT3—hematologic cancer	5.85e-06	0.000144	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—NRAS—hematologic cancer	5.84e-06	0.000144	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GBA—hematologic cancer	5.83e-06	0.000143	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC35B2—hematologic cancer	5.83e-06	0.000143	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NUP214—hematologic cancer	5.82e-06	0.000143	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTP1—hematologic cancer	5.82e-06	0.000143	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—EP300—hematologic cancer	5.79e-06	0.000142	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	5.76e-06	0.000142	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—IDH1—hematologic cancer	5.76e-06	0.000142	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCG2—hematologic cancer	5.7e-06	0.00014	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MTR—hematologic cancer	5.7e-06	0.00014	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCC3—hematologic cancer	5.7e-06	0.00014	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTO1—hematologic cancer	5.7e-06	0.00014	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—TXN—hematologic cancer	5.7e-06	0.00014	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	5.63e-06	0.000139	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ENO2—hematologic cancer	5.59e-06	0.000138	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MAPK3—hematologic cancer	5.59e-06	0.000138	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SPHK1—hematologic cancer	5.57e-06	0.000137	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ABCB1—hematologic cancer	5.51e-06	0.000136	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTP1—hematologic cancer	5.51e-06	0.000135	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—MYC—hematologic cancer	5.44e-06	0.000134	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TGFB1—hematologic cancer	5.43e-06	0.000134	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTT1—hematologic cancer	5.43e-06	0.000134	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—UGT1A1—hematologic cancer	5.35e-06	0.000132	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—NCOR1—hematologic cancer	5.35e-06	0.000132	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—GSTM1—hematologic cancer	5.35e-06	0.000132	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	5.34e-06	0.000131	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MTAP—hematologic cancer	5.33e-06	0.000131	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—SDC1—hematologic cancer	5.3e-06	0.000131	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ABCB1—hematologic cancer	5.21e-06	0.000128	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CRABP1—hematologic cancer	5.21e-06	0.000128	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SLC22A1—hematologic cancer	5.21e-06	0.000128	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALOX5—hematologic cancer	5.08e-06	0.000125	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	5.07e-06	0.000125	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—NCOR1—hematologic cancer	5.06e-06	0.000125	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—GSTM1—hematologic cancer	5.06e-06	0.000125	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—KRAS—hematologic cancer	5.03e-06	0.000124	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	5e-06	0.000123	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NUP98—hematologic cancer	4.92e-06	0.000121	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	4.78e-06	0.000118	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ADCY7—hematologic cancer	4.77e-06	0.000117	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NCOA3—hematologic cancer	4.77e-06	0.000117	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—FHL2—hematologic cancer	4.75e-06	0.000117	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NUP214—hematologic cancer	4.74e-06	0.000117	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—MTHFR—hematologic cancer	4.73e-06	0.000116	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	4.69e-06	0.000115	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AGRN—hematologic cancer	4.66e-06	0.000115	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MTR—hematologic cancer	4.64e-06	0.000114	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCG2—hematologic cancer	4.64e-06	0.000114	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—PIK3CA—hematologic cancer	4.62e-06	0.000114	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ENO2—hematologic cancer	4.55e-06	0.000112	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NQO1—hematologic cancer	4.51e-06	0.000111	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CD44—hematologic cancer	4.51e-06	0.000111	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—MTHFR—hematologic cancer	4.47e-06	0.00011	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—TP53—hematologic cancer	4.47e-06	0.00011	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—IDH2—hematologic cancer	4.42e-06	0.000109	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HMMR—hematologic cancer	4.42e-06	0.000109	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTT1—hematologic cancer	4.42e-06	0.000109	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	4.42e-06	0.000109	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	4.35e-06	0.000107	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—SDC1—hematologic cancer	4.32e-06	0.000106	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—PIK3CA—hematologic cancer	4.28e-06	0.000105	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—HRAS—hematologic cancer	4.27e-06	0.000105	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CYCS—hematologic cancer	4.27e-06	0.000105	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—HSP90AA1—hematologic cancer	4.24e-06	0.000104	CbGpPWpGaD
Montelukast—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	4.17e-06	0.000103	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ARNTL—hematologic cancer	4.15e-06	0.000102	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	4.12e-06	0.000101	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—IL6—hematologic cancer	4.09e-06	0.000101	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	4.07e-06	0.0001	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ACP5—hematologic cancer	4.04e-06	9.94e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CA9—hematologic cancer	4.04e-06	9.94e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.99e-06	9.81e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CG—hematologic cancer	3.97e-06	9.78e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	3.89e-06	9.58e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.82e-06	9.39e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—IDH1—hematologic cancer	3.8e-06	9.35e-05	CbGpPWpGaD
Montelukast—CYSLTR1—Signaling Pathways—AKT1—hematologic cancer	3.77e-06	9.28e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTP1—hematologic cancer	3.76e-06	9.25e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CG—hematologic cancer	3.76e-06	9.25e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTO1—hematologic cancer	3.76e-06	9.24e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—TXN—hematologic cancer	3.76e-06	9.24e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCC3—hematologic cancer	3.76e-06	9.24e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—CREBBP—hematologic cancer	3.68e-06	9.06e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SPHK1—hematologic cancer	3.68e-06	9.05e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CD44—hematologic cancer	3.67e-06	9.03e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NQO1—hematologic cancer	3.67e-06	9.03e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	3.64e-06	8.95e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	3.59e-06	8.84e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ABCB1—hematologic cancer	3.56e-06	8.76e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—UGT1A1—hematologic cancer	3.53e-06	8.69e-05	CbGpPWpGaD
Montelukast—ALOX5—Metabolism—AKT1—hematologic cancer	3.5e-06	8.6e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CD—hematologic cancer	3.49e-06	8.59e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—CREBBP—hematologic cancer	3.48e-06	8.57e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CYCS—hematologic cancer	3.47e-06	8.55e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—NCOR1—hematologic cancer	3.46e-06	8.5e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—GSTM1—hematologic cancer	3.46e-06	8.5e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—HSP90AA1—hematologic cancer	3.45e-06	8.49e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—ALB—hematologic cancer	3.45e-06	8.48e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SLC22A1—hematologic cancer	3.44e-06	8.45e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CRABP1—hematologic cancer	3.44e-06	8.45e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALOX5—hematologic cancer	3.35e-06	8.24e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CD—hematologic cancer	3.3e-06	8.13e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3R1—hematologic cancer	3.3e-06	8.12e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—ALB—hematologic cancer	3.26e-06	8.02e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NUP98—hematologic cancer	3.24e-06	7.98e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ADCY7—hematologic cancer	3.15e-06	7.75e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NCOA3—hematologic cancer	3.15e-06	7.75e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NUP214—hematologic cancer	3.13e-06	7.69e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3R1—hematologic cancer	3.12e-06	7.67e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	3.11e-06	7.64e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MTR—hematologic cancer	3.06e-06	7.53e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCG2—hematologic cancer	3.06e-06	7.53e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTP1—hematologic cancer	3.06e-06	7.53e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—MTHFR—hematologic cancer	3.05e-06	7.52e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CB—hematologic cancer	3.04e-06	7.49e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ENO2—hematologic cancer	3e-06	7.39e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	2.96e-06	7.29e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.91e-06	7.17e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ABCB1—hematologic cancer	2.9e-06	7.13e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CB—hematologic cancer	2.88e-06	7.08e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—SDC1—hematologic cancer	2.85e-06	7e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—GSTM1—hematologic cancer	2.81e-06	6.92e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—NCOR1—hematologic cancer	2.81e-06	6.92e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.69e-06	6.62e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PTEN—hematologic cancer	2.63e-06	6.47e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CG—hematologic cancer	2.57e-06	6.32e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—EP300—hematologic cancer	2.51e-06	6.17e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PTEN—hematologic cancer	2.49e-06	6.12e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—MTHFR—hematologic cancer	2.49e-06	6.12e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CD44—hematologic cancer	2.42e-06	5.96e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NQO1—hematologic cancer	2.42e-06	5.96e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—CREBBP—hematologic cancer	2.38e-06	5.86e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—EP300—hematologic cancer	2.37e-06	5.84e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CYCS—hematologic cancer	2.29e-06	5.64e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	2.28e-06	5.6e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CD—hematologic cancer	2.26e-06	5.55e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—ALB—hematologic cancer	2.23e-06	5.48e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	2.19e-06	5.39e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3R1—hematologic cancer	2.13e-06	5.24e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CG—hematologic cancer	2.09e-06	5.14e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTP1—hematologic cancer	2.02e-06	4.97e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CB—hematologic cancer	1.97e-06	4.84e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—CREBBP—hematologic cancer	1.94e-06	4.77e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.91e-06	4.7e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—PIK3CA—hematologic cancer	1.86e-06	4.57e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.86e-06	4.56e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.86e-06	4.56e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CD—hematologic cancer	1.84e-06	4.52e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—ALB—hematologic cancer	1.81e-06	4.46e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—PIK3CA—hematologic cancer	1.75e-06	4.32e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3R1—hematologic cancer	1.73e-06	4.27e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PTEN—hematologic cancer	1.7e-06	4.18e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.64e-06	4.03e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—EP300—hematologic cancer	1.62e-06	3.99e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CB—hematologic cancer	1.6e-06	3.94e-05	CbGpPWpGaD
Montelukast—PTGS1—Metabolism—AKT1—hematologic cancer	1.52e-06	3.73e-05	CbGpPWpGaD
Montelukast—CYP2A6—Metabolism—AKT1—hematologic cancer	1.43e-06	3.53e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PTEN—hematologic cancer	1.38e-06	3.4e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.38e-06	3.39e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—EP300—hematologic cancer	1.32e-06	3.25e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—CREBBP—hematologic cancer	1.28e-06	3.14e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CD—hematologic cancer	1.21e-06	2.98e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—PIK3CA—hematologic cancer	1.2e-06	2.95e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—ALB—hematologic cancer	1.2e-06	2.94e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3R1—hematologic cancer	1.14e-06	2.81e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CB—hematologic cancer	1.06e-06	2.6e-05	CbGpPWpGaD
Montelukast—CYP2C8—Metabolism—AKT1—hematologic cancer	9.79e-07	2.41e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—PIK3CA—hematologic cancer	9.76e-07	2.4e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PTEN—hematologic cancer	9.12e-07	2.24e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—EP300—hematologic cancer	8.7e-07	2.14e-05	CbGpPWpGaD
Montelukast—CYP2C9—Metabolism—AKT1—hematologic cancer	7.97e-07	1.96e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—PIK3CA—hematologic cancer	6.43e-07	1.58e-05	CbGpPWpGaD
Montelukast—CYP3A4—Metabolism—AKT1—hematologic cancer	5.26e-07	1.29e-05	CbGpPWpGaD
